1054. Deputy Ged Nash asked the Minister for Health his views on the decision of the National Centre for Pharmacoeconomics to refuse reimbursement for life-changing gene therapy Luxturna for inherited retinal diseases which are rare, serious and life limiting; his plans to support the treatment in view of the commitments made in the programme for Government (details supplied); and if he will make a statement on the matter. [1643/21]

Summary

1054. Deputy Ged Nash asked the Minister for Health his views on the decision of the National Centre for Pharmacoeconomics to refuse reimbursement for life-changing gene therapy Luxturna for inherited retinal diseases which are rare, serious and life limiting; his plans to support the treatment in view of the commitments made in the programme for Government (details supplied); and if he will make a statement on the matter. [1643/21]

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

1 official file

• Medicinal Products

  xml · EN · 13 January 2021

  ViewDownloadOpen at official source

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.